Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding:: a report by the Israeli Multidisciplinary rFVIIa task

被引：4
|
作者：
Ariëns, RAS [1 ]
机构：
[1] Univ Leeds, LIGHT, Acad Mol Vasc Med, Leeds LS2 9JT, W Yorkshire, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2005年 / 3卷 / 04期
关键词：
D O I：
10.1111/j.1538-7836.2005.01263.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：649 / 650
页数：2
相关论文
共 50 条
  • [41] Successful use of recombinant factor VII activated (rFVIIa) in a patient with HELLP syndrome and a subclavian vascular lesion
    Fernandez-Rangel, E
    Cedillo-Juarez, J
    Perez-Rada, FJ
    Sanchez-Nava, VM
    Gutierrez-Marfileno, J
    Perez-Cornejo, S
    Rivas-Valenzuela, E
    CRITICAL CARE MEDICINE, 2005, 33 (12) : A182 - A182
  • [42] Clearance of activated recombinant human coagulation factor VII (rFVIIa) in rat and mouse liver
    Johansen, Seested T.
    Nielsen, H. M.
    Christensen, E., I
    Appa, R. S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 357 - 357
  • [43] The efficacy of recombinant activated factor VII (RFVIIA) on hemodiluted and hypothermic human blood in vitro
    Dubick, Michael A.
    Scherer, Michael R.
    Fedyk, Chriselda G.
    Delgado, Angel V.
    Kheirabadi, Bijan S.
    CRITICAL CARE MEDICINE, 2007, 35 (12) : A64 - A64
  • [44] PROLONGED RECOMBINANT ACTIVATED FACTOR-VII (RFVIIA) TREATMENT FOR SEVERE BLEEDING IN A FACTOR-IX-DEFICIENT PATIENT WITH AN INHIBITOR
    SCHMIDT, ML
    SMITH, HE
    GAMERMAN, S
    DIMICHELE, D
    GLAZER, S
    SCOTT, JP
    BRITISH JOURNAL OF HAEMATOLOGY, 1991, 78 (03) : 460 - 463
  • [45] Use of recombinant activated factor VII (rFVIIa-NovoSeven) in the treatment of uncontrolled postsurgical hemorrhage in a patient with deep venous thrombosis and caval filter. A case report
    Marson, F.
    Farnia, A.
    Callegher, L.
    Casagrande, L.
    Surdu, M.
    Sarpellon, M.
    MINERVA ANESTESIOLOGICA, 2006, 72 (7-8) : 675 - 682
  • [46] Can Intravesical Instillation of Recombinant Activated Factor VII (rFVIIa) and Aminocaproic Acid (AA) Stop Bleeding in Hemorrhagic Cystitis?
    Douglas, Jennifer Reichbach
    Willumsen, Silvia
    Andreansky, Martin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S304 - S304
  • [47] The emerging role of recombinant activated Factor VII (rFVIIa) in the treatment of blunt traumatic haemorrhage
    Rizoli, SB
    Chughtai, T
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (01) : 73 - 81
  • [48] Recombinant Activated Coagulation Factor VII (rFVIIa) for Treatment of the Tracheobronchial Bleeding in Mechanically Ventilated (MV) Thrombocytopenic Patients (pts)
    Galstian, Gennadii M.
    Polevodova, Olesya A.
    Zorenko, Vladimir Yu.
    Savchenko, Valeriy G.
    BLOOD, 2018, 132
  • [49] Activated recombinant coagulation factor VII (rfVIIa) for clinical management of hematopoietic stem cell transplantation-associated bleeding
    Cetkovsky, P
    Salaj, P
    Vitek, A
    Markova, M
    Sponerova, D
    Pohlreich, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S224 - S224
  • [50] Use of Recombinant Activated Factor VII to Arrest Uncontrolled Bleeding: A Case Series
    Alsayegh, Faisal
    Fakeir, Aisha
    Alhumood, Salah
    Abdumalek, Kafaya
    Matar, Hatem
    Samaul, Isaac
    Nampoory, Narayanan
    Kabalawi, Housam
    Mousa, Shaker A.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (02) : 225 - 232
12345